A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Autor: Negri Aranguren, Florencia ^*, Cranco, Santiago ^*, Shanley, Claudia ^*, Fernandez, Isolda I. ^*, Prates, Maria Virginia, Otero, Victoria ^*, Fiad, Lorena ^*, Foncuberta, Maria Cecilia, Miodosky, Marcela ^*, Pavlovsky, Miguel A., Kuminsky, Gustavo ^*, Bordone, Javier ^*, Wannesson, Bruno ^*, Corso, Ariel Corso ^*, Riveros, Dardo ^*, Marquez, Marisa ^*, Jarchum, Gustavo ^*, Jarchum, Maria Sol ^*, Cerutti, Ider Ramon ^*, Bistmas, Alicia ^*, Tamashiro, Monica ^*, De Stefano, Giselda ^*, Navieckas, Alicia ^*, Cugliari, Silvana ^*, Negri Aranguren, Pedro ^*, Balaguer, Gabriela ^*, Tosin, Maria ^*, Remaggi, Guillermina ^*, Altuve, Juan ^*, Garcia, Juan Jose, Ferrari, Luciana C. ^*, Klein, Graciela ^*, Guanchiale, Luciana ^*, Beligoy, Luis ^*, Marull, Mariana ^*, Dacunto, Maria Cecilia ^*, Zerga, Marta Elisa ^*, Kurgansky, Nicolas Matias ^*, Pujol, Marcelo ^*, Taus, Rossana L. ^*, Sackman, Federico ^*, Canosa, Veronica Cintia ^*, Cruset, Soledad ^*, Riddick, Maximiliano ^*, Pavlovsky, Astrid ^*

Publikováno v: In Blood 8 December 2017 130 Supplement 1:4089-4089